Clinical Trials
18 trialsNCT05368090 2026-05-08
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
Haukeland University Hospital
Phase NA Recruiting
NCT07470580 2026-03-13
ADERADHTA2
University Hospital, Toulouse
Phase NA Not yet recruiting
NCT07027254 2025-06-18
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
Seoul National University Hospital
Phase NA Recruiting
NCT06500000 2024-07-15
The Plasma Metabolomics Profiling of Primary Aldosteronism
Third Military Medical University
Completed
NCT06090617 2024-03-19
WHYSKI
University Hospital Padova
Unknown
NCT06050057 2023-09-22
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
University Hospital Olomouc
Recruiting
NCT05991856 2023-08-15
Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma
Third Affiliated Hospital, Sun Yat-Sen University
Recruiting
NCT05815069 2023-08-08
[18F]AlF-NOTA-pentixather PET/CT in Patients With Suspected Primary Hyperaldosteronism
Sichuan Provincial People's Hospital
Phase NA Unknown
NCT05839483 2023-07-17
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis
Zhongnan Hospital
Phase NA Unknown
NCT05826080 2023-04-24
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Unknown
NCT04761354 2021-02-18
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
UMC Utrecht
Completed
NCT04071561 2019-08-28
Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions
University of Basel
Completed
NCT01267747 2019-06-07
PAPPHY
University Hospital Padova
Completed
NCT01567111 2019-03-11
MIA
Helsinki University Central Hospital
Phase NA Completed
NCT02030587 2017-04-25
LARFA
Chinese University of Hong Kong
Phase NA Unknown
NCT02150213 2016-12-05
Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Novartis
Phase 2 Completed
NCT01096654 2015-07-16
SPARTACUS
Radboud University Medical Center
Phase 3 Completed
NCT01234220 2013-01-15
AVIS
University Hospital Padova
Completed